SEC Form 4 · accession 0001209191-15-087010
SYNCHRONOSS TECHNOLOGIES INC · SNCR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James M McCormick
Director · 10% Owner
Period of report
Dec 23, 2015
Accepted (ET)
Dec 28, 2015 · 6:14 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001131554
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 23, 2015 | M | 25,000 | $8.98 | A | 2,216,144 | D | |
| Common StockF1 | Dec 23, 2015 | S | 25,000 | $35.86 | D | 2,191,144 | D | |
| Common StockF2 | holding | — | — | — | 870,000 | I | by Vertek Corporation |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Purchase)F3 | $8.98 | Dec 23, 2015 | M | 25,000 | D | Feb 10, 2007 | Feb 10, 2016 | Common Stock | 25,000 | 0 | D |
Explanation of responses
- F1The weighted average sales price is reported as stock sales were aggregated for reporting purposes. The per share transaction price ranged from $35.54 to $36.04. The reporting person will provide, upon request from an appropriate party, the per share sales volume and prices.
- F2The Reporting Person is the Chief Executive Officer and sole stockholder of Vertek Corporation. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in the report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 for any other purpose.
- F3The option shall become exercisable with respect to 1/4 of the shares subject to the option when the Reporting Person completes one year of continuous service after 2/10/2006 and monthly thereafter.
Remarks
***All of the sales reported on this Form were effected pursuant to an approved Rule 10b5-1 trading plan.***